Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002398 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations
A NA study, sponsored by Gilead Sciences.
- Completed
- Registry status
- NA
- Development phase
NCT00002398: Completed NA study, sponsored by Gilead Sciences.
NCT00002398 is a NA study that has completed, run by Gilead Sciences. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002398, a NA study, has completed, sponsored by Gilead Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this study is to see if it is safe and effective to give adefovir plus other anti-HIV drugs to HIV-infected patients who have failed other anti-HIV drug combinations. This study will try to make adefovir available to all AIDS patients who need it. Some patients do not respond to anti-HIV drug combinations, even when different combinations are tried. Adefovir may be able to help these patients fight HIV.
Interventions
- DRUG Levocarnitine
- DRUG Adefovir dipivoxil
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002398 record still lists
NCT00002398 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Levocarnitine is the first listed.
NCT00002398 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002398 about?
NCT00002398 is a clinical study titled "Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations". The purpose of this study is to see if it is safe and effective to give adefovir plus other anti-HIV drugs to HIV-infected patients who have failed other anti-HIV drug combinations. This study will try to make adefovir available to all AIDS patients who need it. Some patients do not respond to anti...
What is the current status of trial NCT00002398?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002398?
The interventions under investigation include: Levocarnitine (DRUG), Adefovir dipivoxil (DRUG).
Who is sponsoring clinical trial NCT00002398?
This trial is sponsored by Gilead Sciences, which has 504 total clinical trials registered on ClinicalTrials.gov.